MFDS — authorised 20 December 2005
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
🇰🇷 Nexavar in South Korea
MFDS authorised Nexavar on 20 December 2005
Marketing authorisation
Nexavar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Nexavar approved in South Korea?
Yes. MFDS authorised it on 20 December 2005.
Who is the marketing authorisation holder for Nexavar in South Korea?
BAYER HLTHCARE holds the South Korean marketing authorisation.